NCT01552928View on ClinicalTrials.gov

Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 29, 2012

Primary Completion Date

July 25, 2012

Study Completion Date

July 25, 2012

Conditions
Healthy
Interventions
DRUG

Anagrelide 0.5 mg

0.5mg Anagrelide single oral dose

DRUG

Anagrelide 2.5 mg

2.5mg Anagrelide single oral dose

DRUG

Moxifloxacin

400 mg Moxifloxacin single oral dose

DRUG

Placebo

Anagrelide placebo + Moxifloxacin placebo single oral dose

Trial Locations (1)

Unknown

Biotrial, Rueil-Malmaison

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY